Perineal Consequences of Twin Pregnancies According to Mode of Delivery (JUMODA-CP)

November 17, 2025 updated by: Centre Hospitalier Universitaire de Nīmes

This is an ancillary study to the "JUMODA" (National Prospective and Comparative Study on the Mode of Delivery of Twins) study: please see NCT01987063.

The main objective of this study is to investigate the role of the mode of delivery (vaginal versus cesarean) as a risk factor for the occurrence of urinary incontinence at 3 months post-delivery in primiparous women delivering twins after 34 weeks of pregnancy.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The secondary objectives of this study are to compare the following elements between primiparous mothers giving birth to twins vaginally versus by caesarean section after 34 weeks of pregnancy (comparisons will be made at 3 months ant at 12 months post-partum):

A. Diagnosis, type and severity of urinary incontinence via the ICIQ-UI questionnaire

B. Urinary, anorectal and perineal symptoms via the PFDI-20 questionnaire

C. Quality of life related to urinary, anorectal and pelvic floor symptoms via the PFIQ-7 questionnaire

D. Sexuality via the PISQ-12 questionnaire

E. General quality of life via the SF-12 questionnaire

Study Type

Observational

Enrollment (Actual)

3039

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Montpellier, France, 34295
        • CHRU de Montpellier - Hôpital Arnaud de Villeneuve
      • Nîmes, France, 30029
        • CHRU de Nîmes - Hôpital Universitaire Carémeau

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

This is an ancillary to the "JUMODA" study (please see NCT01987063). The study population is composed of primiparous women pregnant with twins (non primiparous patients in the study JUMODA will therefore not includable), giving birth after 34 weeks to 2 live children.

Description

Inclusion Criteria:

  • The patient must have given his/her informed and signed consent
  • The patient must be insured or beneficiary of a health insurance plan
  • The patient is available for 12 months of follow-up following delivery
  • The patient was included in the JUMODA study
  • Primiparous
  • Birth of 2 live children after 34 weeks of pregnancy

Exclusion Criteria:

  • Adult patient under guardianship
  • Patient under judicial protection
  • It proves impossible to correctly inform the patient
  • Birth occurring before 34 weeks of pregnancy
  • Birth not resulting in 2 living children

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Vaginal birth

Patients in the group give birth vaginally.

Intervention: Questionnaires sent by mail

The questionnaires necessary for the study are mailed to patients at 3 and 12 months post-partum.
Cesaren section

Patients in this group give birth via cesarean section.

Intervention: Questionnaires sent by mail

The questionnaires necessary for the study are mailed to patients at 3 and 12 months post-partum.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Presence/absence of urinary incontinence
Time Frame: 3 months post-partum
Defined by a response of 1 to 5 on the first question of the ICIQ-UI questionnaire.
3 months post-partum

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The ICIQ-UI questionnaire
Time Frame: 3 months post-partum
ICIQ-Urinary Incontinence Form
3 months post-partum
The PFDI-20 questionnaire
Time Frame: 3 months post-partum
3 months post-partum
The ICIQ-UI questionnaire
Time Frame: 12 months post-partum
ICIQ-Urinary Incontinence Form
12 months post-partum
The PFDI-20 questionnaire
Time Frame: 12 months post-partum
12 months post-partum
The PFIQ-7 questionnaire
Time Frame: 3 months post-partum
3 months post-partum
The PFIQ-7 questionnaire
Time Frame: 12 months post-partum
12 months post-partum
The PISQ-12 questionnaire
Time Frame: 3 months post-partum
3 months post-partum
The PISQ-12 questionnaire
Time Frame: 12 months post-partum
12 months post-partum
The SF-12 questionnaire
Time Frame: 3 months post-partum
3 months post-partum
The SF-12 questionnaire
Time Frame: 12 months post-partum
12 months post-partum

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Renaud de Tayrac, MD, PhD, Centre Hospitalier Universitaire de Nīmes

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2014

Primary Completion (Actual)

March 1, 2015

Study Completion (Actual)

March 1, 2016

Study Registration Dates

First Submitted

February 7, 2014

First Submitted That Met QC Criteria

February 7, 2014

First Posted (Estimated)

February 11, 2014

Study Record Updates

Last Update Posted (Estimated)

November 19, 2025

Last Update Submitted That Met QC Criteria

November 17, 2025

Last Verified

April 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy, Multiple

Clinical Trials on Questionnaires sent by mail

Subscribe